Skip to main content

Engineers Gate Manager LP

SEC CIK
0001620220
Latest filing
Aug 14, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Engineers Gate Manager LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
3,066
Value
$1.52M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of VRTX by Engineers Gate Manager LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,066$1.52M<0.1%−10,752−77.8%ReducedHolders
Q1 202613,818$6.17M0.1%+9,154+196.3%AddedHolders
Q4 20254,664$2.11M<0.1%−10,179−68.6%ReducedHolders
Q3 202514,843$5.81M0.1%+14,843NewHolders
Q1 20250$00.0%−11,599−100.0%Sold outHolders
Q4 202411,599$4.67M0.1%+11,599NewHolders
Q3 20240$00.0%−13,386−100.0%Sold outHolders
Q2 202413,386$6.27M0.1%+881+7.0%AddedHolders
Q1 202412,505$5.23M0.1%+4,886+64.1%AddedHolders
Q4 20237,619$3.10M0.1%−1,096−12.6%ReducedHolders
Q3 20238,715$3.03M0.1%+5,422+164.7%AddedHolders
Q2 20233,293$1.16M<0.1%+779+31.0%AddedHolders
Q1 20232,514$792.1K<0.1%−27,783−91.7%ReducedHolders
Q4 202230,297$8.75M0.5%+27,959+1,195.9%AddedHolders
Q3 20222,338$677.0K<0.1%−2,773−54.3%ReducedHolders
Q2 20225,111$1.44M0.1%−2,153−29.6%ReducedHolders
Q1 20227,264$1.90M0.1%−2,678−26.9%ReducedHolders
Q4 20219,942$2.18M0.1%−33,802−77.3%ReducedHolders
Q3 202143,744$7.93M0.5%+16,851+62.7%AddedHolders
Q2 202126,893$5.42M0.3%+24,300+937.1%AddedHolders
Q1 20212,593$557.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.